United Therapeutics (UTH) Q2 2023 Earnings Report
4 Followers
DE:UTH Q2 2023 EPS Results
- Actual EPS
- EUR 4.66
- Consensus EPS
- EUR 4.06
- Beat/Miss
- Beat by +EUR 0.60
- One Year Ago EPS
- EUR 2.14
DE:UTH Q2 2023 Revenue Results
- Actual Revenue
- EUR 530.01M
- Expected Revenue
- EUR 465.75M
- Beat/Miss
- Beat by +EUR 64.26M
- YoY Revenue Growth
- +27.76%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/02/2023
- Time
- Before Open
- Conference Call
- Wednesday, August 2, 2023
DE:UTH Upcoming Earnings
United Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:UTH Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 5.43- | 6.84 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 5.345.07 | 6.36 | -20.25% (-1.29) | |
| Aug 05, 2026 | 2026 (Q2) | 6.106.46 | 5.7 | 13.42% (+0.76) | |
| May 06, 2026 | 2026 (Q1) | 6.225.17 | 5.89 | -12.22% (-0.72) | |
| Feb 25, 2026 | 2025 (Q4) | 6.346.84 | 5.5 | 24.39% (+1.34) | |
| Oct 29, 2025 | 2025 (Q3) | 6.506.36 | 5.68 | 12.05% (+0.68) | |
| Jul 30, 2025 | 2025 (Q2) | 6.485.70 | 5.2 | 9.57% (+0.50) | |
| Apr 30, 2025 | 2025 (Q1) | 5.955.89 | 5.48 | 7.46% (+0.41) | |
| Feb 26, 2025 | 2024 (Q4) | 5.695.50 | 3.87 | 41.97% (+1.63) | |
| Oct 30, 2024 | 2024 (Q3) | 5.805.68 | 4.78 | 18.77% (+0.90) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
